MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s13181-020-00802-7

Медицинская библиотека · Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2020

A Pharmacokinetic Analysis of Hemodialysis for Metformin-Associated Lactic Acidosis.

Harding Stephen A, Biary Rana, Hoffman Robert S, Su Mark K, Howland Mary Ann

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Although hemodialysis is recommended for patients with severe metformin-associated lactic acidosis (MALA), the amount of metformin removed by hemodialysis is poorly documented. We analyzed endogenous clearance and hemodialysis clearance in a patient with MALA.

METHODS

A 62-year-old man with a history of type II diabetes mellitus presented after several days of vomiting and diarrhea and was found to have acute kidney injury (AKI) and severe acidemia. Initial serum metformin concentration was 315.34 μmol/L (40.73 μg/mL) (typical therapeutic concentrations 1-2 μg/mL). He underwent 6 h of hemodialysis. We collected hourly whole blood, serum, urine, and dialysate metformin concentrations. Blood, urine, and dialysate samples were analyzed, and clearances were determined using standard pharmacokinetic calculations.

RESULTS

The total amount of metformin removed by 6 h of hemodialysis was 888 mg, approximately equivalent to one therapeutic dose. Approximately 142 mg of metformin was cleared in the urine during this time. His acid-base status and creatinine improved over the following days. No further hemodialysis was required.

CONCLUSION

We report a case of MALA likely secondary to AKI and severe volume depletion. The patient improved with supportive care, sodium bicarbonate, and hemodialysis. Analysis of whole blood, serum, urine, and dialysate concentrations showed limited efficacy of hemodialysis in the removal of metformin from blood, contrary to previously published data. Despite evidence of acute kidney injury, a relatively large amount of metformin was eliminated in the urine while the patient was undergoing hemodialysis. These data suggest that clinical improvement is likely due to factors besides removal of metformin.

Для цитирования: Harding Stephen A, Biary Rana, Hoffman Robert S, Su Mark K, Howland Mary Ann. A Pharmacokinetic Analysis of Hemodialysis for Metformin-Associated Lactic Acidosis.. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2020. DOI: 10.1007/s13181-020-00802-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.